• Citer

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial.

par Salgado, Roberto;Denkert, Carsten;Campbell, Christine;Savas, Peter;Nucifero, Paolo;Aura, Claudia Monica;de Azambuja, Evandro ;Eidtmann, Holger;Ellis, Catherine;Baselga, José;Piccart-Gebhart, Martine ;Michiels, Stefan ;Bradbury, Ian;Sotiriou, Christos ;Loi, Sherene
Référence JAMA oncology, 1, 4, page (448-454)
Publication Publié, 2015-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial.
Auteur:	Salgado, Roberto; Denkert, Carsten; Campbell, Christine; Savas, Peter; Nucifero, Paolo; Aura, Claudia Monica; de Azambuja, Evandro; Eidtmann, Holger; Ellis, Catherine; Baselga, José; Piccart-Gebhart, Martine; Michiels, Stefan; Bradbury, Ian; Sotiriou, Christos; Loi, Sherene
Informations sur la publication:	JAMA oncology, 1, 4, page (448-454)
Statut de publication:	Publié, 2015-07
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
	Sciences bio-médicales et agricoles
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2374-2437
	info:doi/10.1001/jamaoncol.2015.0830
	info:pii/2279849
	info:scp/84982889739
	info:pmid/26181252